Oneness Biotech Advances SNS851 Obesity Drug Candidate to Multiple-Ascending Dose Phase I Trial
Oneness Biotech (TW: 4743) has completed the single-ascending dose (SAD) portion of its Phase I clinical trial of SNS851, an
Read More
Pharma
Caliway’s CBL-514 Shows Significant, Sustained Pain Reduction in Phase II Dercum’s Disease Trial
Taiwan’s Caliway Biopharmaceuticals (TW: 6919) has reported positive final results from a Phase II trial of CBL-514D, demonstrating statistically significant
Read More
Merry Life Biomedical Advances Global Phase II Trial of TML-6 for Early Alzheimer’s Disease
Taiwan’s Merry Life Biomedical has advanced its locally-developed oral drug candidate TML-6 into a global Phase II clinical trial for
Read More
Lai touts Taiwan’s precision oncology push
President Lai Ching-te lauded Taiwan’s efforts in cancer research and treatment in a video address marking the 20th anniversary of
Read More
Anxo Pharmaceutical’s AX251 Completes World’s First Patient Dosing
Anxo Pharmaceutical (TW: 6677), a developer of drug delivery technologies, announced in a press release on the 14th of September
Read More
Taiwan’s Bora Pharmaceuticals Posts Second-Highest Monthly Revenue of NT$2.18 Billion in August; Sale-Leaseback Deal to Add Over NT$16 Million in Annual Cash Flow
Bora Pharmaceuticals reported August consolidated revenue of NT$2.18 billion, up 15% month-over-month and 59.22% year-over-year, marking its second-highest monthly figure
Read More